Unique ID issued by UMIN | UMIN000019852 |
---|---|
Receipt number | R000022932 |
Scientific Title | Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2. |
Date of disclosure of the study information | 2015/11/19 |
Last modified on | 2020/05/22 21:55:32 |
Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2.
Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of ADH1B and ALDH2.
Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2.
Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of ADH1B and ALDH2.
Japan |
squamous cell carcinoma of the esophagus and the head and neck
Gastroenterology |
Malignancy
NO
Evaluation of the risk of metachronous squamous cell carcinoma of the esophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus according to genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2.
Efficacy
The incidence of metachronous squamous cell carcinoma of the esophagus and the head and neck according to genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Other |
It collected the saliva in all cases.
20 | years-old | <= |
Not applicable |
Male and Female
1 It is possible to take a saliva.
2 Written informed consent was obtained from all patients.
1 Surgery was added.
2 Officer has determined to be inappropriate.
3 Less than 20 years old.
4 During pregnancy.
300
1st name | Yuichi |
Middle name | |
Last name | Shimizu |
Hokkaido University Graduate School of Medicine
Department of Gastroenterology
060-8638
kita 14 jyou nishi 5 chome, kitaku, Sapporo
011-716-1161
abiko1982@gmail.com
1st name | Satoshi |
Middle name | |
Last name | Abiko |
Hokkaido University Graduate School of Medicine
Department of Gastroenterology
060-8638
kita 14 jyou nishi 5 chome, kitaku, Sapporo
011-716-1161
abiko1982@gmail.com
Hokkaido University Graduate School of Medicine
None
Self funding
Hokkaido University Graduate School of Medicine
kita 14 jyou nishi 5 chome, kitaku, Sapporo
011-716-1161
abiko1982@gmail.com
NO
2015 | Year | 11 | Month | 19 | Day |
https://pubmed.ncbi.nlm.nih.gov/29423536/?from_term=abiko+S+hokudai&from_pos=2
Published
https://pubmed.ncbi.nlm.nih.gov/29423536/?from_term=abiko+S+hokudai&from_pos=2
158
Results: Multivariate analyses revealed that inactive heterozygous ALDH2 [hazard ratio (HR) 2.25] and alcohol consumption after ER (HR 1.94) were independently associated with the risk of developing secondary SCC. Moreover, inactive heterozygous ALDH2 (HR 4.39) and alcohol consumption after the ER (HR 2.82) were independently associated with the risk of a third SCC.
2020 | Year | 05 | Month | 22 | Day |
Background: Metachronous multiple squamous cell carcinoma (SCC) of the esophagus and the head and neck is commonly observed in patients who have previously undergone endoscopic resection (ER) for SCC of the esophagus (ESCC). We evaluated the risk for developing metachronous SCC following ER for ESCC based on the genetic polymorphisms for alcohol dehydrogenase-1B (ADH1B) and aldehyde dehydrogenase-2 (ALDH2) as well as the alcohol consumption and smoking habits.
Methods: We studied 158 patients who underwent ER for ESCC (median follow-up 80 months). Genotyping of ADH1B/ALDH2 was performed using saliva sampling. The alcohol consumption and smoking histories of the patients before and after the ER were documented.
no
Results: Multivariate analyses revealed that inactive heterozygous ALDH2 [hazard ratio (HR) 2.25] and alcohol consumption after ER (HR 1.94) were independently associated with the risk of developing secondary SCC. Moreover, inactive heterozygous ALDH2 (HR 4.39) and alcohol consumption after the ER (HR 2.82) were independently associated with the risk of a third SCC. We analyzed 110 patients who had a history of moderate or heavy alcohol consumption before the ER. The 3-year cumulative incidence rates of secondary SCC in the temperance (n = 65) and non-temperance groups (n = 45) were 14.0 and 42.1% (p = 0.0002). Further, the 5-year cumulative incidence rates of a third SCC in the temperance and non-temperance groups were 0 and 15.6% (p = 0.0011), respectively. In addition, the 7-year cumulative incidence rates of a fourth SCC in the temperance and non-temperance groups were 0 and 15.3% (p = 0.0015), respectively.
Completed
2015 | Year | 08 | Month | 01 | Day |
2016 | Year | 07 | Month | 01 | Day |
2015 | Year | 11 | Month | 19 | Day |
2016 | Year | 09 | Month | 01 | Day |
2016 | Year | 12 | Month | 01 | Day |
Exploratory studies using new specimens
2015 | Year | 11 | Month | 18 | Day |
2020 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022932